Literature DB >> 23748235

Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis.

Yu Sawada1, Motonobu Nakamura2, Toshinori Bito3, Jun-Ichi Sakabe4, Rieko Kabashima-Kubo2, Ryosuke Hino2, Miwa Kobayashi2, Yoshiki Tokura4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23748235     DOI： 10.1038/jid.2013.244

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  12 in total

1.  Cholinesterase levels in the skin in cholinogenic urticaria and pruritus.

Authors:  I A MAGNUS; R H THOMPSON
Journal:  Br J Dermatol       Date:  1956-09       Impact factor: 9.302

2.  Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin.

Authors:  Yu Sawada; Motonobu Nakamura; Toshinori Bito; Shoko Fukamachi; Rieko Kabashima; Kazunari Sugita; Ryosuke Hino; Yoshiki Tokura
Journal:  J Invest Dermatol       Date:  2010-07-08       Impact factor: 8.551

Review 3.  Consensus meeting on the definition of physical urticarias and urticarial vasculitis.

Authors:  A K Black; F Lawlor; M W Greaves
Journal:  Clin Exp Dermatol       Date:  1996-11       Impact factor: 3.470

4.  Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines.

Authors:  J L Pype; L J Dupont; P Menten; E Van Coillie; G Opdenakker; J Van Damme; K F Chung; M G Demedts; G M Verleden
Journal:  Am J Respir Cell Mol Biol       Date:  1999-10       Impact factor: 6.914

5.  Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase.

Authors:  P Conti; X Pang; W Boucher; R Letourneau; M Reale; R C Barbacane; J Thibault; T C Theoharides
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

6.  CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli.

Authors:  Yuichiro Tsunemi; Hidehisa Saeki; Koichiro Nakamura; Daisuke Nagakubo; Takashi Nakayama; Osamu Yoshie; Shinji Kagami; Kiyo Shimazu; Takafumi Kadono; Makoto Sugaya; Mayumi Komine; Koji Matsushima; Kunihiko Tamaki
Journal:  Eur J Immunol       Date:  2006-08       Impact factor: 5.532

7.  Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission.

Authors:  Y Nakazato; N Tamura; A Ohkuma; K Yoshimaru; K Shimazu
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

Review 8.  Pathogenesis of cholinergic urticaria in relation to sweating.

Authors:  Toshinori Bito; Yu Sawada; Yoshiki Tokura
Journal:  Allergol Int       Date:  2012-10-25       Impact factor: 5.836

9.  Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis.

Authors:  S Takahagi; T Tanaka; K Ishii; H Suzuki; Y Kameyoshi; H Shindo; M Hide
Journal:  Br J Dermatol       Date:  2008-09-20       Impact factor: 9.302

10.  [The reactivity of dispersed human lung mast cells and peripheral blood basophils to acetylcholine].

Authors:  K Takahashi; R Soda; T Kishimoto; T Matsuoka; M Maeda; M Araki; Y Tanimoto; N Kawada; I Kimura; H Komagoe
Journal:  Arerugi       Date:  1992-06
View more
  9 in total

Review 1.  Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management.

Authors:  Atsushi Fukunaga; Ken Washio; Mayumi Hatakeyama; Yoshiko Oda; Kanako Ogura; Tatsuya Horikawa; Chikako Nishigori
Journal:  Clin Auton Res       Date:  2017-04-05       Impact factor: 4.435

Review 2.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  A case of idiopathic pure sudomotor failure associated with prolonged high levels of serum carcinoembryonic antigen.

Authors:  Yoshihiko Nakazato; Naotoshi Tamura; Kei Ikeda; Toshimasa Yamamoto; Yoshiki Tokura
Journal:  Clin Auton Res       Date:  2016-08-04       Impact factor: 4.435

4.  Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.

Authors:  Yiyu Wang; Jörg Scheffel; Carolina Ayala Vera; Wei Liu; Dorothee Günzel; Dorothea Terhorst-Molawi; Marcus Maurer; Sabine Altrichter
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 5.  Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Shinya Imamura; Mayuko Mizuno; Takeshi Fukumoto; Ken Washio
Journal:  Am J Clin Dermatol       Date:  2022-09-15       Impact factor: 6.233

6.  Cell Adhesion Molecule 1 (CADM1) Is an Independent Prognostic Factor in Patients with Cutaneous Squamous Cell Carcinoma.

Authors:  Natsuko Saito-Sasaki; Yu Sawada; Etsuko Okada; Motonobu Nakamura
Journal:  Diagnostics (Basel)       Date:  2021-05-04

Review 7.  Idiopathic pure sudomotor failure: A review and two cases.

Authors:  Albert T Young; Raagini S Yedidi; Jodie Raffi; Timothy H McCalmont; Jeffrey North; Alyson Brinker; Timothy G Berger; Jenny E Murase
Journal:  Int J Womens Dermatol       Date:  2020-12-24

8.  Gross cystic disease fluid protein 15 in stratum corneum is a potential marker of decreased eccrine sweating for atopic dermatitis.

Authors:  Koji Kamiya; Jun-Ichi Sakabe; Hayato Yamaguchi; Takahiro Suzuki; Tsuyoshi Yatagai; Masahiro Aoshima; Taisuke Ito; Yoshiki Tokura
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

9.  Prognosis after steroid pulse therapy and seasonal effect in acquired idiopathic generalized anhidrosis.

Authors:  Tadatsune Iida; Michiko Nakamura; Minako Inazawa; Takichi Munetsugu; Makiko Nishida; Tomoko Fujimoto; Yoshiyuki Sasaki; Yuichiro Ohshima; Yoshihiko Nakazato; Takeshi Namiki; Hiroo Yokozeki
Journal:  J Dermatol       Date:  2020-11-04       Impact factor: 4.005
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.